Clearbridge Health Limited – Detailed Use of Placement Proceeds
Clearbridge Health Limited Announces Detailed Use of Placement Proceeds
Date: 13 November 2025
Key Highlights
- Successful Placement: Clearbridge Health Limited (“the Company”) has completed a significant placement of 990,000,000 new ordinary shares and 659,999,996 free, detachable, transferrable, non-listed warrants.
- Funds Raised: The placement raised approximately S\$1.86 million in net proceeds after deducting related expenses of S\$120,000.
- Transparency in Utilisation: The Company has provided a detailed breakdown of how these funds have been deployed to date, which is critical information for investors and shareholders.
- Ongoing Disclosure: The Company commits to ongoing, periodic announcements regarding the utilisation of these proceeds as material disbursements occur.
Detailed Use of Proceeds
As of the date of this announcement, the allocation and utilisation of the net placement proceeds are as follows:
| Use of Net Placement Proceeds |
Allocation (S\$’000) |
Amount Utilised (S\$’000) |
Balance (S\$’000) |
| General working capital requirements of the Group |
1,860 |
1,007 |
853 |
Breakdown of Utilised Proceeds
- Payments for payroll-related expenses and Directors’ fees: S\$535,000
- Payments to suppliers: S\$61,000
- Payments for professional fees: S\$346,000
- Rental Expenses: S\$49,000
- Other expenses: S\$16,000
- Total utilised: S\$1,007,000
What Shareholders Need to Know
- The use of proceeds is in line with what was previously disclosed, ensuring that the funds are being used for the Company’s stated general working capital needs.
- Approximately 54% of the net proceeds have already been utilised, primarily for operational activities such as payroll, directors’ fees, professional fees, and supplier payments. This indicates a focus on maintaining business continuity and supporting ongoing operations.
- S\$853,000 remains available for future working capital requirements, which could be important for the Group’s liquidity and future operational flexibility.
- Frequent and transparent updates on the use of proceeds are promised, allowing shareholders to closely monitor the Company’s financial stewardship and cash flow management going forward.
Potential Price-Sensitive Information
- The successful completion of the placement and the detailed transparency in fund allocation could bolster investor confidence in management’s governance and capital management.
- Significant utilisation towards payroll and professional fees suggests ongoing investment in human capital and external expertise, which could support the Company’s growth or restructuring initiatives.
- Any deviation from the intended use or unexpected rapid depletion of the remaining proceeds could be price-sensitive in the future. Investors should watch for subsequent announcements regarding the remaining S\$853,000.
Ongoing Commitments
The Company has committed to making periodic announcements on the utilisation of net placement proceeds whenever material disbursements are made, and will provide status reports in its annual reports and financial results announcements until the proceeds are fully utilised.
Disclaimer: This article is for informational purposes only and does not constitute investment advice or an offer to buy or sell any securities. Investors should conduct their own due diligence and consult with professional advisors before making any investment decisions. The information herein is based on the latest company announcement and may be subject to change without prior notice.
View Clearbridge Historical chart here
